Ruoyu Huang Selected Research

Ruoyu Huang Research Topics

Disease

17	Neoplasms (Cancer) 12/2023 - 01/2017
17	Glioma (Gliomas) 07/2023 - 01/2017
5	Glioblastoma (Glioblastoma Multiforme) 01/2024 - 03/2018
3	Pain (Aches) 01/2024 - 01/2020
3	Trigeminal Neuralgia (Tic Douloureux) 01/2024 - 01/2020
2	Chronic Pain 01/2024 - 01/2020
2	Neuralgia (Stump Neuralgia) 01/2023 - 10/2019
1	Plasmacytoma 01/2024
1	Bronchopneumonia 12/2023
1	Brain Edema (Cerebral Edema) 12/2023
1	Hemorrhage 12/2023
1	Necrosis 12/2023
1	Poisoning 12/2023
1	Facial Pain (Myofacial Pain) 01/2021
1	Carcinogenesis 01/2021
1	Seizures (Absence Seizure) 01/2021
1	Hyperalgesia 01/2020
1	Brain Neoplasms (Brain Tumor) 12/2019

Drug/Important Bio-Agent (IBA)

7	RNA (Ribonucleic Acid)IBA 01/2021 - 01/2017
5	Proteins (Proteins, Gene)FDA Link 01/2021 - 10/2018
4	Biomarkers (Surrogate Marker)IBA 07/2020 - 01/2018
3	Brain-Derived Neurotrophic Factor (BDNF)IBA 01/2024 - 10/2019
3	Long Noncoding RNAIBA 01/2024 - 01/2018
3	Indicators and Reagents (Reagents)IBA 01/2021 - 01/2018
3	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 01/2021 - 07/2019
2	Small Interfering RNA (siRNA)IBA 01/2023 - 01/2021
2	Immune Checkpoint InhibitorsIBA 12/2021 - 01/2017
2	EnzymesIBA 12/2021 - 01/2017
2	Phosphotransferases (Kinase)IBA 01/2021 - 11/2018
2	palmatineIBA 01/2021 - 01/2020
2	LigandsIBA 01/2021 - 01/2021
2	Messenger RNA (mRNA)IBA 07/2019 - 01/2017
1	Carbamazepine (Tegretol)FDA LinkGeneric 01/2024
1	Tumor Necrosis Factor Receptor-Associated Peptides and ProteinsIBA 12/2023
1	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 12/2023
1	propylene dichlorideIBA 12/2023
1	Capsules (Microcapsules)IBA 12/2023
1	SolventsIBA 12/2023
1	Hormones (Hormone)IBA 07/2023
1	OxysterolsIBA 07/2023
1	CholesterolIBA 07/2023
1	Membrane LipidsIBA 07/2023
1	SteroidsIBA 07/2023
1	Purinergic P2X4 ReceptorsIBA 01/2023
1	Oxidoreductases (Dehydrogenase)IBA 12/2021
1	Protein Isoforms (Isoforms)IBA 12/2021
1	AldehydesIBA 12/2021
1	Aldehyde DehydrogenaseIBA 12/2021
1	Sermorelin (Sermorelin Acetate)FDA Link 03/2021
1	CCAAT-Enhancer-Binding Protein-alphaIBA 01/2021
1	Galectins (Galectin)IBA 01/2021
1	Purinergic P2X7 ReceptorsIBA 01/2021
1	Extracellular Matrix ProteinsIBA 12/2020
1	fibulinIBA 12/2020
1	Epidermal Growth Factor (EGF)IBA 12/2020
1	Adenosine Triphosphate (ATP)IBA 07/2020
1	ElementsIBA 07/2020
1	salicylhydroxamic acid (SHAM)IBA 01/2020
1	MethyltransferasesIBA 12/2019
1	ErbB Receptors (EGF Receptor)IBA 12/2019
1	Telomerase (Telomerase Reverse Transcriptase)IBA 12/2019
1	Temozolomide (Temodar)FDA LinkGeneric 12/2019
1	epidermal growth factor receptor VIIIIBA 12/2019
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 12/2019
1	dihydromyricetinIBA 10/2019
1	SurvivinIBA 07/2019
1	Adenosine DeaminaseIBA 01/2018
1	DCMP Deaminase (Deoxycytidylate Deaminase)IBA 01/2017
1	Gemcitabine FDA Link 01/2017
1	SolutionsIBA 01/2017
1	AntibodiesIBA 01/2017

Therapy/Procedure

5	Therapeutics 12/2021 - 01/2017
2	Drug Therapy (Chemotherapy) 01/2021 - 01/2020
2	Immunotherapy 12/2020 - 01/2017
2	Chemoradiotherapy 01/2020 - 12/2019
1	Radiotherapy 01/2021